INNOVIVA, INC.

INVA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-85.3M
Depreciation & Amortization $5.5M
Depreciation $4.3M
Amortization
Stock-Based Compensation $20.0M
Net Cash from Operating Activities $-58.1M
Investing Activities
Capital Expenditures $744.0K
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities
Net Change in Cash
Free Cash Flow $-58.8M
← Newer Page 3 of 3 Older →